Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bupropion for the Treatment of Apathy in Alzheimer Disease
Franziska Maier, Annika Spottke, Jan‐Philipp Bach, et al.
JAMA Network Open (2020) Vol. 3, Iss. 5, pp. e206027-e206027
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Antidepressant use and cognitive decline in patients with dementia: a national cohort study
Minjia Mo, Tamar Abzhandadze, Minh Tuan Hoang, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 3
Advancements in the development of multi-target directed ligands for the treatment of Alzheimer’s disease
Naveen Kumar, Vijay Kumar, Piyush Anand, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 61, pp. 116742-116742
Closed Access | Times Cited: 70
The neurobiology of apathy in depression and neurocognitive impairment in older adults: a review of epidemiological, clinical, neuropsychological and biological research
David C. Steffens, Mario Fahed, Kevin J. Manning, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 42
Distinguishing features of depression in dementia from primary psychiatric disease
Daniel Fisher, Jeffrey T. Dunn, Hongxin Dong
Discover Mental Health (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials
Moyra E. Mortby, Lawrence Adler, Luis Agüera-Ortíz, et al.
American Journal of Geriatric Psychiatry (2021) Vol. 30, Iss. 2, pp. 119-147
Open Access | Times Cited: 46
Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis
Michael David, Martina Del Giovane, Kathy Liu, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 10, pp. 1080-1090
Open Access | Times Cited: 35
Pharmacological Management of Apathy in Dementia
Laiba Azhar, Raphael W. Kusumo, Giovanni Marotta, et al.
CNS Drugs (2022) Vol. 36, Iss. 2, pp. 143-165
Closed Access | Times Cited: 27
Emotion Processing Dysfunction in Alzheimer’s Disease: An Overview of Behavioral Findings, Systems Neural Correlates, and Underlying Neural Biology
Shefali Chaudhary, Simon Zhornitsky, Herta H. Chao, et al.
American Journal of Alzheimer s Disease & Other Dementias® (2022) Vol. 37
Open Access | Times Cited: 27
An Update on Apathy in Alzheimer’s Disease
Helena Dolphin, Adam H. Dyer, Cathy McHale, et al.
Geriatrics (2023) Vol. 8, Iss. 4, pp. 75-75
Open Access | Times Cited: 12
Clinical Practice Guidelines for Dementia: Recommendations for the Pharmacological Treatment of Behavioral and Psychological Symptoms
Gihwan Byeon, Dong Woo Kang, Yeshin Kim, et al.
Dementia and Neurocognitive Disorders (2025) Vol. 24, Iss. 1, pp. 24-24
Open Access
Systematic review of the efficacy of pharmacological and non-pharmacological interventions for improving quality of life of people with dementia
D. E. A. LUXTON, N Thorpe, Edward J. Crane, et al.
The British Journal of Psychiatry (2025), pp. 1-13
Closed Access
Antidepressants and Apathy in Geriatric Psychiatry: First Do No Harm
Christopher B. Morrow, J. Craig Nelson
Deleted Journal (2025)
Open Access
Alzheimer’s Disease in Lebanon: Exploring Genetic and Environmental Risk Factors—A Comprehensive Review
Mohamad A. Khaled, Hadi Al-Jamal, Layla Tajer, et al.
Journal of Alzheimer s Disease (2024) Vol. 99, Iss. 1, pp. 21-40
Closed Access | Times Cited: 3
Apathy in Parkinson’s Disease: Defining the Park Apathy Subtype
Ségolène De Waele, Patrick Cras, David Crosiers
Brain Sciences (2022) Vol. 12, Iss. 7, pp. 923-923
Open Access | Times Cited: 13
Apathy in patients with Alzheimer's disease is a cost‐driving factor
Christopher Kruse, Franziska Maier, Annika Spottke, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 7, pp. 2853-2864
Open Access | Times Cited: 8
The brief Dimensional Apathy Scale: A short clinical assessment of apathy
Ratko Radaković, Sarah McGrory, Siddharthan Chandran, et al.
The Clinical Neuropsychologist (2019) Vol. 34, Iss. 2, pp. 423-435
Open Access | Times Cited: 19
A Systematic Review of Pharmacological Interventions for Apathy in Aging Neurocognitive Disorders
Christos Theleritis, Kostas Siarkos, Anastasios Politis, et al.
Brain Sciences (2023) Vol. 13, Iss. 7, pp. 1061-1061
Open Access | Times Cited: 5
Management of Psychiatric Symptoms in Dementia
Yavuz Ayhan, Selam A. Yoseph, Bruce L. Miller
Neurologic Clinics (2022) Vol. 41, Iss. 1, pp. 123-139
Closed Access | Times Cited: 7
Medications for apathy in dementia
Jen Potter, Wyatt Baloun, Bradley LeDrew, et al.
Canadian Family Physician (2024) Vol. 70, Iss. 6, pp. 395-395
Open Access | Times Cited: 1
Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review
Sarah Dahlberg, Ellen T. Chang, Sheila R. Weiss, et al.
Diabetes Metabolic Syndrome and Obesity (2022) Vol. Volume 15, pp. 3049-3067
Open Access | Times Cited: 6
Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials
Mengting Qin, Jing Wu, Qidong Zhou, et al.
Journal of Psychiatric Research (2022) Vol. 155, pp. 371-379
Open Access | Times Cited: 5
Side effects based network construction and drug repositioning of ropinirole as a potential molecule for Alzheimer’s disease: an in-silico , in-vitro , and in-vivo study
Amritha Chakkittukandiyil, Saurav Chakraborty, Ram Kothandan, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 20, pp. 10785-10799
Closed Access | Times Cited: 2
Drug Repositioning: A Monetary Stratagem to Discover a New Application of Drugs
Ankur Rohilla, Seema Rohilla
Current Drug Discovery Technologies (2023) Vol. 21, Iss. 1
Closed Access | Times Cited: 1
Apathy in Dementia
Allen Lee, Vincent Mok, Linda C. W. Lam
(2024), pp. 83-87
Closed Access
The major challenges with pharmacologic management of chronic traumatic encephalopathy
Brendan P. Campbell, Katherine W. Turk, Andrew E. Budson
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 11, pp. 1035-1039
Closed Access
Page 1 - Next Page

Scroll to top